Tsou, P., Khanna, D., & Sawalha, A. H. (2019). Identifying CYR61 as a Potential Anti-fibrotic and Pro-angiogenic Mediator in Scleroderma. Arthritis Rheumatol.
Styl cytowania ChicagoTsou, Pei-Suen, Dinesh Khanna, i Amr H. Sawalha. "Identifying CYR61 As a Potential Anti-fibrotic and Pro-angiogenic Mediator in Scleroderma." Arthritis Rheumatol 2019.
Styl cytowania MLATsou, Pei-Suen, Dinesh Khanna, i Amr H. Sawalha. "Identifying CYR61 As a Potential Anti-fibrotic and Pro-angiogenic Mediator in Scleroderma." Arthritis Rheumatol 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..